Disclosures for "Phase 1 Clinical Data with Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Participants"
-
Dr. Hartman has received personal compensation for serving as an employee of Centessa Pharmaceuticals. Dr. Hartman has stock in Centessa Pharmaceuticals.
-
Dr. Kong has received personal compensation for serving as an employee of Centessa Pharmaceuticals.
-
Dr. RATTI has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Centessa Pharmaceuticals . Dr. RATTI has stock in Centessa Pharmaceuticals.
-
Mr. Accardi has received personal compensation for serving as an employee of Centessa. Mr. Accardi has stock in Centessa.
-
Dr. Saha has received personal compensation for serving as an employee of Centessa Pharmaceuticals.
-
Dr. IM has received personal compensation for serving as an employee of Centessa . Dr. IM has stock in Centessa.